Literature DB >> 28677263

Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Floor J E Lubberman1, Hans Gelderblom2, Carli M Wilmer1, Dina M Kweekel3, Ingrid M E Desar4, Angela Colbers1, David Burger1, Winette T A van der Graaf4,5, Nielka van Erp1.   

Abstract

Entities:  

Keywords:  acidic beverage; imatinib; major gastrectomy; pharmacokinetics

Mesh：

Substances：

Year:  2017        PMID： 28677263      PMCID： PMC5595978          DOI： 10.1111/bcp.13333

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib.

Authors:  Changhoon Yoo; Min-Hee Ryu; Byung Woog Kang; Shin-Kyo Yoon; Baek-Yeol Ryoo; Heung-Moon Chang; Jae-Lyun Lee; Mo Youl Beck; Tae Won Kim; Yoon-Koo Kang
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

2.  A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.

Authors:  Nielka P van Erp; Djoeke de Wit; Henk-Jan Guchelaar; Hans Gelderblom; Trees J Hessing; Jan den Hartigh
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-08-17       Impact factor: 3.205

Review 3.  Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors.

Authors:  Annelieke E C A B Willemsen; Floor J E Lubberman; Jolien Tol; Winald R Gerritsen; Carla M L van Herpen; Nielka P van Erp
Journal:  Drug Discov Today       Date:  2016-03-17       Impact factor: 7.851

4.  The Concise Guide to PHARMACOLOGY 2015/16: Transporters.

Authors:  Stephen Ph Alexander; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

5.  Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Authors:  Floor J E Lubberman; Hans Gelderblom; Carli M Wilmer; Dina M Kweekel; Ingrid M E Desar; Angela Colbers; David Burger; Winette T A van der Graaf; Nielka van Erp
Journal:  Br J Clin Pharmacol       Date:  2017-07-04       Impact factor: 4.335

6.  Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinib.

Authors:  Brian D Furmanski; Shuiying Hu; Ken-Ichi Fujita; Lie Li; Alice A Gibson; Laura J Janke; Richard T Williams; John D Schuetz; Alex Sparreboom; Sharyn D Baker
Journal:  Clin Cancer Res       Date:  2013-06-21       Impact factor: 12.531

7.  Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.

Authors:  Roelof W F van Leeuwen; Robert Peric; Koen G A M Hussaarts; Emma Kienhuis; Nikki S IJzerman; Peter de Bruijn; Cor van der Leest; Henk Codrington; Jeroen S Kloover; Bronno van der Holt; Joachim G Aerts; Teun van Gelder; Ron H J Mathijssen
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

8.  Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

Authors:  George D Demetri; Yanfeng Wang; Elisabeth Wehrle; Amy Racine; Zariana Nikolova; Charles D Blanke; Heikki Joensuu; Margaret von Mehren
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

Review 9.  Gastrointestinal stromal tumour.

Authors:  Brian P Rubin; Michael C Heinrich; Christopher L Corless
Journal:  Lancet       Date:  2007-05-19       Impact factor: 79.321

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
  10 in total
  4 in total

1.  Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Authors:  Floor J E Lubberman; Hans Gelderblom; Carli M Wilmer; Dina M Kweekel; Ingrid M E Desar; Angela Colbers; David Burger; Winette T A van der Graaf; Nielka van Erp
Journal:  Br J Clin Pharmacol       Date:  2017-07-04       Impact factor: 4.335

2.  The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumours.

Authors:  Floor J E Lubberman; Winette T A van der Graaf; Lei Xu; Adriaan Cleton; George D Demetri; Hans Gelderblom; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2019-08-19       Impact factor: 4.335

Review 3.  Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose.

Authors:  Kim Westerdijk; Ingrid M E Desar; Neeltje Steeghs; Winette T A van der Graaf; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2020-01-21       Impact factor: 4.335

4.  Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics.

Authors:  Jeffry Adiwidjaja; Alan V Boddy; Andrew J McLachlan
Journal:  Front Pharmacol       Date:  2020-01-30       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.